Abstract
Deoxycoformycin (dCF) is an investigational nucleoside with significant activity in hairy cell leukemia, cutaneous T‐cell lymphoma, and chronic lymphocytic leukemia. During a 4‐year period, 11 patients have experienced cardiac events as a complication of dCF therapy under NCI sponsorship. The cases are presented and recommendations for the administration of dCF to patients with pre‐existing heart disease are made.
Original language | English (US) |
---|---|
Pages (from-to) | 245-247 |
Number of pages | 3 |
Journal | American Journal of Hematology |
Volume | 38 |
Issue number | 3 |
DOIs | |
State | Published - Nov 1991 |
Externally published | Yes |
Keywords
- 2′‐deoxycoformycin
- cardiac side effects
- pentostatin
ASJC Scopus subject areas
- Hematology